Ardelyx, Inc. (ARDX)
6.22
-0.25
(-3.86%)
USD |
NASDAQ |
Mar 03, 16:00
6.22
0.00 (0.00%)
After-Hours: 16:40
Ardelyx Cash from Investing (Quarterly) : 3.776M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -419.50M |
| MannKind Corp. | -291.96M |
| Vertex Pharmaceuticals, Inc. | -288.10M |
| PTC Therapeutics, Inc. | 34.01M |
| Fate Therapeutics, Inc. | 27.63M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 20.95M |
| Cash from Financing (Quarterly) | 0.557M |
| Free Cash Flow | -43.98M |
| Free Cash Flow Per Share (Quarterly) | 0.0845 |
| Free Cash Flow to Equity (Quarterly) | 20.25M |
| Free Cash Flow to Firm (Quarterly) | 28.30M |
| Free Cash Flow Yield | -2.93% |